NOVUS THERAPEUTICS INC's ticker is NVUS and the CUSIP is 67011N105. A total of 20 filers reported holding NOVUS THERAPEUTICS INC in Q3 2020. The put-call ratio across all filers is - and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2020 | $12,000 | +140.0% | 12,775 | 0.0% | 0.00% | – |
| Q2 2020 | $5,000 | +25.0% | 12,775 | 0.0% | 0.00% | – |
| Q1 2020 | $4,000 | -71.4% | 12,775 | -50.0% | 0.00% | – |
| Q4 2019 | $14,000 | +75.0% | 25,550 | +100.0% | 0.00% | – |
| Q3 2019 | $8,000 | -33.3% | 12,775 | 0.0% | 0.00% | – |
| Q2 2019 | $12,000 | -74.5% | 12,775 | +9.1% | 0.00% | – |
| Q1 2019 | $47,000 | +30.6% | 11,712 | -50.0% | 0.00% | – |
| Q4 2018 | $36,000 | -33.3% | 23,424 | +100.0% | 0.00% | – |
| Q3 2018 | $54,000 | – | 11,712 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| BVF INC/IL | 828,876 | $522,000 | 0.06% |
| 683 Capital Management, LLC | 623,102 | $386,000 | 0.04% |
| Orbimed Advisors | 3,183,314 | $1,974,000 | 0.04% |
| Boxer Capital, LLC | 324,383 | $201,000 | 0.02% |
| Hayden Royal, LLC | 10,000 | $6,000 | 0.01% |
| Virtu Financial LLC | 14,109 | $9,000 | 0.00% |
| VANGUARD GROUP INC | 62,761 | $39,000 | 0.00% |
| VICTORY CAPITAL MANAGEMENT INC | 2,110 | $1,000 | 0.00% |
| ROYAL BANK OF CANADA | 254 | $0 | 0.00% |
| CONCOURSE FINANCIAL GROUP SECURITIES, INC. | 0 | $0 | 0.00% |